Company History
| 1983.06 | BMG was founded by Dr. HYON with the cooperation of Kyoto University. |
| 1986.06 | Through collaboration of Gunze Ltd., BMG started production of Polyglycolide (PGA) which is used for producing biodegradable suture. (First mass production in Japan, receiving production arrival from Ministry of Health & Welfare) |
| 1986.06 | Moved the company building to Minami-ku, Kyoto City and began manufacturing polyglycolic acid (raw material for bioabsorbable sutures). |
| 1995.10 | A new company building was completed and the company name was changed to BMG Co., Ltd. in the same year. |
| 1996.04 | Commenced production of Poly-L-lactide (PLLA) for biodegradable bone fixture. |
| 1997.04 | Commenced production of Guided Tissue Regeneration (GTR) membrane for dentistry. |
| 1998.09 | Commenced production of Poly(L-lactide-co-ε-caprolactone)(LCL) for producing biodegradable monofilament sutures. |
| 2002.02 | Signed a patent license agreement with US Biomet regarding sliding parts for artificial joints with excellent wear resistance. |
| 2003.05 | Establishment of new biodegradable and absorbable polymer production equipment and expansion of company building. |
| 2004.04 | Obtained approval from the Ministry of Health, Labor and Welfare to manufacture “ACRYSHOT”, a material for denture bases that is gentle on the human body. |
| 2005.03 | Obtained permission from Kyoto Prefecture to manufacture medical equipment for the human-friendly denture base material “ACRYSHOT” |
| 2006.03 | The Japan Science and Technology Agency established BioVerde Co., Ltd. with the aim of commercializing the pre-venture project ``Research on the creation of long-term room-temperature storage solution for biological tissue'' as a technology seed. |
| 2006.10 | Started sales of refrigerated preservation solution for biological tissue “TelioKeep” |
| 2008.04 | Insurance coverage begins for “ACRYSHOT”, a thermoplastic resin for denture bases. |
| 2009.04 | Started sales of cryopreservation solution for cells "CryoScarless DMSO-Free" |
| 2010.07 | Started sales of "StemCell Keep" vitrification cryopreservation solution for primate ES/iPS cells |
| 2011.06 | Exchanged R&D contract with NIPRO CORPORATION regarding BMG-original medical adhesive |
| 2011.11 | At the “41st Kyoto City Venture Company Appraisal Committee”, our business plan “Commercialization of medical adhesives with excellent performance and high safety” was additionally certified as A rank. |
| 2012.02 | Started sales of antioxidant Epigallocatechin gallate (EGCG) |
| 2012.04 | Started sales of recombinant human serum albumin “IBUKI（Recombinant, Human Serum Albumin）” |
| 2018.08 | Made BioVerde Co., Ltd. a 100% subsidiary. |
| 2021.05 | Started sales of poly-ε-caprolactone (PCL) and BioDegmer filament for 3D printers |
| 2021.05 | Started sales of CPLL solution "CryoBov for Sperm" for freezing bovine semen and "CryoBov for Embryo" for freezing bovine fertilized eggs (embryos) |
| 2021.06 | Accepted investment totaling 600 million yen from Toagosei Co., Ltd. and Universal Materials Incubator Co., Ltd. |
| 2021.12 | Accepted investment totaling 130 million yen from Ono Pharmaceutical Co., Ltd. and Kyoto Bank Lease Capital Co., Ltd. |
| 2021.12 | Obtained ISO 13485 certification for raw materials for surgical adhesives and medical adhesives from the Japan Management Association. |
| 2022.02 | Signed a joint development agreement with Asahi Kasei Corporation to develop new applications for the medical adhesive "LYDEX" |
| 2022.06 | Our subsidiary BioVerde Co., Ltd. and Heartseed Co., Ltd. enter into a joint development agreement regarding cryopreservation solution for iPS cells. |
| 2022.10 | Obtained first-class medical device manufacturing and sales license from Kyoto Prefecture. |
| 2022.12 | Absorbed and merged with BioVerde Co., Ltd. |
| 2024.05 | The homepage has been renewed |
BMG Inc.
〒601-8023
45 Minamimatsunoki-cho, Higashikujo, Minami-ku, Kyoto 601−8023, JAPAN
+81-75-681-0787
©2025 BMG Inc.